default author photo

Michael Townsend

Government of the United States of America - Centers for Disease Control and Prevention (CDC)

SCHOLARLY PAPERS

2

DOWNLOADS

138

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Serological Responses to the Mva-Based Jynneos Monkeypox Vaccine in a Cohort of Participants from the Democratic Republic of Congo

Number of pages: 15 Posted: 07 Oct 2022
Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Democratic Republic of Congo - Ministry of Health, Democratic Republic of Congo - Ministry of Health, Centers for Disease Control and Prevention, Democratic Republic of the Congo, Kinshasa School of Public Health, Kinshasa School of Public Health, Kinshasa School of Public Health, Democratic Republic of Congo - Ministry of Health, Democratic Republic of Congo - Ministry of Health, Democratic Republic of Congo, Kinshasa School of Public Health, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Division of High Consequence Pathogens and Pathology, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC) and Government of the United States of America - Centers for Disease Control and Prevention (CDC)
Downloads 99 (694,528)

Abstract:

Loading...

JYNNEOS, MVA, Monkeypox, Orthopoxvirus, Serology, Antibody, Immunogenicity

2.

Maternal–Fetal Immune Remodeling After Non-Severe SARS-CoV-2 in Pregnancy: A Prospective Kenyan Cohort Study

Number of pages: 18 Posted: 19 Apr 2026
Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, Kenya Medical Research Institute (KEMRI), Centers for Disease Control and Prevention, Kenya Medical Research Institute (KEMRI) - Centre for Global Health Research, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Kenya Medical Research Institute (KEMRI), Centers for Disease Control and Prevention, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Kenya Medical Research Institute (KEMRI) - Centre for Global Health Research, Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, Government of the United States of America - Centers for Disease Control and Prevention (CDC) and Government of the United States of America - Influenza Division
Downloads 39 (1,222,651)

Abstract:

Loading...

Cytokines, Pregnancy, SARS-CoV-2, Neonatal immunity, Kenya, Resource-constrained settings (LMICs)